Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Molecular Systems Biology|April 23, 2026
SyntheMol-RL: a flexible reinforcement learning framework for designing easily synthesizable antibioticsKyle Swanson, Gary Liu, Denise B Catacutan, et al.Plos Pathogens|March 2, 2016
Influenza Virus Targets Class I MHC-Educated NK Cells for ImmunoevasionAhmad Bakur Mahmoud, Megan M Tu, Andrew Wight, et al.Plos Pathogens|November 5, 2016
Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for ImmunoevasionAhmad Bakur Mahmoud, Megan M Tu, Andrew Wight, et al.Nature Microbiology|January 3, 2025
Exploiting the fitness cost of metallo-β-lactamase expression can overcome antibiotic resistance in bacterial pathogensMegan M Tu, Lindsey A Carfrae, Kenneth Rachwalski, et al.Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate CancerMegan M Tu, Mark Clemons, Carol Stober, et al.Nature Microbiology|May 1, 2023
Inhibiting fatty acid synthesis overcomes colistin resistanceLindsey A Carfrae, Kenneth Rachwalski, Shawn French, et al.Cellular & Molecular Immunology|October 3, 2018
NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infectionsElias Abou-Samra, Zachary Hickey, Oscar A Aguilar, et al.ACS Infectious Diseases|March 23, 2022
Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic AdjuvantCraig R MacNair, Maya A Farha, Michael H Serrano-Wu, et al.Communications Biology|November 28, 2020
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M Tu, Hany A Abdel-Hafiz, Robert T Jones, et al.Blood|June 5, 2012
Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient miceSimon Bélanger, Megan M Tu, Mir Munir Ahmed Rahim, et al.Pageof 4